We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

58 hedge funds and large institutions have $42.2M invested in Niagen Bioscience in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 10

29% more capital invested

Capital invested by funds: $32.7M → $42.2M (+$9.45M)

0.89% more ownership

Funds ownership: 17.32% → 18.21% (+0.89%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less call options, than puts

Call options by funds: $95K | Put options by funds: $98K

5% less funds holding

Funds holding: 61 → 58 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

Holders
58
Holders Change
-3
Holders Change %
-4.92%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
15
Reduced
10
Closed
11
Calls
$95K
Puts
$98K
Net Calls
-$3K
Net Calls Change
-$3K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$597K
2
TCM
Tieton Capital Management
Washington
+$596K
3
GIP
Granite Investment Partners
California
+$283K
4
MMA
Miracle Mile Advisors
California
+$234K
5
UBS Group
UBS Group
Switzerland
+$154K

Top Sellers

Rank Fund Capital Flow
1
OC
Oppenheimer & Co
New York
-$172K
2
KCM
Knoll Capital Management
Florida
-$154K
3
Morgan Stanley
Morgan Stanley
New York
-$87.1K
4
Citadel Advisors
Citadel Advisors
Florida
-$72K
5
Bank of America
Bank of America
North Carolina
-$53.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCA
51
Peddock Capital Advisors
Massachusetts
$14K – – –
BBNA
52
Bremer Bank National Association
Minnesota
$13K +$10.2K +2,816 New
HS
53
Horan Securities
United States
$9K – – –
RE
54
RBC Europe
United Kingdom
$3.23K – – –
AA
55
AlphaMark Advisors
Kentucky
$3K – – –
WWM
56
Willingdon Wealth Management
North Carolina
$3K +$2.88K +800 New
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$2K – – –
VFA
58
Valeo Financial Advisors
Indiana
$2K – – –
OC
59
Oppenheimer & Co
New York
– -$172K -50,000 Closed
KCM
60
Knoll Capital Management
Florida
– -$154K -45,019 Closed
Citadel Advisors
61
Citadel Advisors
Florida
– -$72K -21,050 Closed
LPL Financial
62
LPL Financial
California
– -$42K -12,234 Closed
Creative Planning
63
Creative Planning
Kansas
– -$34K -10,001 Closed
TRCT
64
Tower Research Capital (TRC)
New York
– -$16K -4,545 Closed
CPA
65
Cowen Prime Advisors
New York
– -$8K -2,200 Closed
Bank of Montreal
66
Bank of Montreal
Ontario, Canada
– -$2K -544 Closed
CG
67
Cutler Group
California
– -$1K -500 Closed
BOPW
68
Brandywine Oak Private Wealth
Pennsylvania
– -$1K -300 Closed
1 2
3

NAGE Hedge Fund Activity: Q1 2019 in Review

58 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q1 2019, worth a combined $42.2M — up 29% from $32.7M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of NAGE and 8 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 15 added.

The largest buyer was Vanguard Group, adding an estimated $597K. The largest seller was Oppenheimer & Co, exiting entirely with an estimated $172K sold.

  • 58 institutional investors held Niagen Bioscience (NAGE) as of Q1 2019, down from 61 in Q4 2018.
  • Funds reported $42.2M of Niagen Bioscience stock for Q1 2019, up 29% quarter-over-quarter.
  • 8 funds opened new Niagen Bioscience positions in Q1 2019 and 11 closed out, a net change of -3 holders.
  • The largest Niagen Bioscience buyer in Q1 2019 was Vanguard Group, an estimated $597K added.
  • The largest Niagen Bioscience seller in Q1 2019 was Oppenheimer & Co, an estimated $172K sold.

Based on aggregated 13F filings for Q1 2019.